Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

Abstract
No abstract available
Funding Information
  • WHO
  • Wellcome Trust
  • Médecins Sans Frontières
  • Norwegian Ministry of Foreign Affairs
  • Canadian Government
  • Canadian Institutes of Health Research
  • International Development Research Centre
  • Department of Foreign Affairs, Trade and Development
  • European Commission Innovative Medicines Initiative
  • European Commission
  • Research Council of Norway
  • Wellcome Trust
  • UK Department of International Development
  • Guinean Ministry of Health
  • Norwegian Ministry of Foreign Affairs
  • US Department of Defense
  • Public Health Agency of Canada
  • Swiss Agency for Therapeutic Products
  • Bill & Melinda Gates Foundation
  • Health Canada
  • European Commission